This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Oximesa’s Esteve Teijin acquisition gets full probe in Spain

( June 10, 2025, 08:15 GMT | Official Statement) -- MLex Summary: Oximesa, a Spanish provider of home respiratory services, has seen the national antitrust authority open a full investigation into its plan to acquire control of rival Esteve Teijin Healthcare. Esteve Teijin is the only mid-sized competitor currently exerting pressure on the two largest participants — Oximesa and Air Liquide — and the deal could remove such competition. The concentration also poses threats for the distribution of healthcare products and home respiratory services, the CNMC said.Statement follows. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login